This product is compatible with our RapidReader App and Lateral Flow Scanner. Discover how to streamline your organization's drug screening workflow with our integrated solutions. Learn More.
Rapid Response® 10 Parameter Multi-Drug Test Panel with PCP provide a simple, cost-effective way to screen urine samples for multiple drugs and metabolites with clear results in 5 minutes. The compact dip-card format is easy to store, easy to use, and designed for testing where speed and consistency matter.
This product is FDA CLIA Waived for use at the Point-of-Care.
Available Parameters
| Drug | Cut-off (ng/mL) |
| Cocaine (COC) | 300 |
| Amphetamines (AMP) | 1000 |
| Methamphetamine (MET) | 1000 |
| Marijuana (THC) | 50 |
| Methadone (MTD) | 300 |
| Opiate (OPI) | 2000 |
| Phencyclidine (PCP) | 25 |
| Barbiturates (BAR) | 300 |
| Benzodiazepines (BZO) | 300 |
| Tricyclic Antidepressants (TCA) | 1000 |
Built to reduce user error
The one-step lateral flow format is designed to standardize testing steps and support consistent administration across teams and shifts. Each panel includes a procedural control (C-line) to confirm proper specimen flow.
RapidReader App
Lateral Flow Scanner
- Test Panels
- SVT/Adulterant Color Chart (if applicable)
- Product Insert
Rapid Response® 10 Parameter Multi-Drug Test Panel with PCP provide a simple, cost-effective way to screen urine samples for multiple drugs and metabolites with clear results in 5 minutes. The compact dip-card format is easy to store, easy to use, and designed for testing where speed and consistency matter.
This product is FDA CLIA Waived for use at the Point-of-Care.
Available Parameters
| Drug | Cut-off (ng/mL) |
| Cocaine (COC) | 300 |
| Amphetamines (AMP) | 1000 |
| Methamphetamine (MET) | 1000 |
| Marijuana (THC) | 50 |
| Methadone (MTD) | 300 |
| Opiate (OPI) | 2000 |
| Phencyclidine (PCP) | 25 |
| Barbiturates (BAR) | 300 |
| Benzodiazepines (BZO) | 300 |
| Tricyclic Antidepressants (TCA) | 1000 |
Built to reduce user error
The one-step lateral flow format is designed to standardize testing steps and support consistent administration across teams and shifts. Each panel includes a procedural control (C-line) to confirm proper specimen flow.
Test up to 10 parameters simultaneously
Control and Test Regions marked for easy interpretation
Longer detection window than saliva tests
Results Interpretation are as follows:
Positive: Only one colored band appears, in the control region (C). No apparent colored band appears in the test region (T).
Negative: Two colored bands appear on the membrane. One band appears in the control region (C) and another band appears in the test region (T).
Invalid: NO line appears in the C – Control region, then the result is Invalid.
Please refer to the product insert for more details.
The Rapid Response® Multi-Drug Test Panel is compatible with the Rapid Response® Lateral Flow Scanner, a revolutionary workflow solution redefining the approach to drug screen reporting in staffing agencies, treatment centers, and laboratories. The Lateral Flow Scanner captures results of up to 5 test panels, allows the operator to confirm the results and then transmits the data directly to your organization’s EMR, ATS or LIS with the click of a button.
The Rapid Response® Multi-Drug Test Panel is compatible with the The RapidReader App, a state-of-the-art screening software application that allows users to streamline their drug screening process. The RapidReader App uses AI technology to capture drug screen results from a photo, records and auto-fills the predicted results, and generates a Chain of Custody in just 2 ½ minutes. Learn more about The RapidReader App.
You can find the RapidReader Instructional YouTube Video below.
The BTNX Rapid Response Tests undergo regular evaluation using proficiency samples from AAB (American Association of Bioanalysts) and CAP (College of American Pathologists).
Open the pouch, dip the panel, wait 5 minutes, and read results by visual interpretation of colored lines. No specialized instrumentation is required for standard use.
Always read and follow the instructions provided with the kit when performing the test.
- Treatment programs: intake, monitoring, and ongoing compliance workflows
- Staffing and workplace testing: efficient screening with simplified reporting
- Law enforcement and probation: rapid screening support for field or departmental workflows
|
Parameter |
Calibrator (combined if different) |
Cut-off (ng/mL) (combined) |
|
COC |
Benzoylecgonine |
300 |
|
AMP |
d-Amphetamine |
1000 |
|
MET |
d-Methamphetamine |
1000 |
|
THC |
11-nor-?9-THC-9-COOH |
50 |
|
MTD |
Methadone |
300 |
|
OPI |
Opiates; Morphine |
2000 |
|
PCP |
Phencyclidine |
25 |
|
BAR |
Secobarbital |
300 |
|
BZO |
Oxazepam |
300 |
|
TCA |
Nortriptyline |
1000 |
The BTNX Rapid Response® Multi-Drug Test Panel is a urine drug screening panel used to screen for multiple drugs and metabolites. It uses a compact dip-card format and provides clear results in 5 minutes.
The BTNX Multi-Drug Test Panel can be configured with custom parameter combinations from 1 to 16 drugs. Please reach out to our sales team for assistance with configuration.
A negative result means the test did not detect the targeted drug or metabolite at or above the applicable cut-off level for that panel. A negative result does not necessarily rule out drug presence below the cut-off level.
Digital reading tools can support more consistent result capture and workflow documentation, depending on the product and testing program. For this product, compatibility with both the RapidReader App and the Lateral Flow Scanner is available.
Yes. Our Rapid Response® Multi-Drug Test Panel is compatible with the RapidReader App.
Yes, certain BTNX Multi-Drug Test Panel configurations are CLIA waived. Because available configurations and regulatory status vary, BTNX can help you select a panel that matches your testing needs, cut-off requirements, use setting, and region.
Yes. BTNX Multi-Drug Test Panels can be configured to test for multiple drugs or metabolites on a single panel. Available configurations may vary by drug parameters, cut-off levels, intended use, and region.
A positive result should be handled according to the testing program’s procedures. In many settings, positive or non-negative screening results are sent for confirmatory testing before a final decision is made.
No. Each BTNX Multi-Drug Test Panel is intended for single use only. A new panel should be used for each urine sample.
Multi-Drug Test Panels are screening tests. A positive or non-negative result may require confirmatory laboratory testing, depending on the testing program, regulatory requirements, and intended use setting.
Urine Storage: It is recommended the collected fresh urine to be tested immediately. Fresh urine maybe stored at room temperature (25ºC) for up to 4 hours or to be refrigerated (2-8ºC) for up to 48 hours prior to performing the test. For prolonged storage, specimens may be frozen and stored below -20ºC. Specimens that have been refrigerated must be brought to room temperature prior to testing. Previously frozen specimens must be thawed, brought to room temperature, and mixed thoroughly prior to testing.
NOTE: Urine specimens and all materials coming in contact with them should be handled and disposed of as if capable of transmitting infection. Avoid contact with skin by wearing gloves and proper laboratory attire.
- Please note that certain products may only be available in specific regions; kindly consult with a sales representative for further information regarding product availability.
- The information provided on this website is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare professional regarding any medical concerns or conditions.
- Our products are intended for use as specified in the product documentation. It is important to carefully read and follow all instructions provided with the product.